Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.
Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to secure CMS coverage for obesity drugs.
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...
Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems a ...
Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...
Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.